德勤：2024年GenAI正在改变医疗技术的游戏规则吗（英文版）

Across industries, artificial intelligence (AI) and Generative AI (GenAI) discussions are moving from potential to value realization.1 For medtech companies, this value can be in the form of cost reductions, cost avoidance, and new revenue generation. To assess where medtech companies have realized value2 from AI and GenAI and what could be next, the Deloitte Center for Health Solutions surveyed 85 leaders from medtech organizations during the summer of 2024 and conducted follow-up int